← Back to patent-cliff list
Bifonazole/Triamcinolone Acetonide
Tier C — Watch / tradeBifonazole/Triamcinolone Acetonide
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：CYP51A1, GR
Indications (approved)：Pityriasis versicolor, 外阴阴道炎, Tinea, 足癣
Regional status
US
-
EU
-
China
Phase III
2014-09-18
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bifonazole/Triamcinolone Acetonide?
Approved indications include: Pityriasis versicolor, 外阴阴道炎, Tinea, 足癣.
When does the Bifonazole/Triamcinolone Acetonide patent expire?
No public expiry year is available for Bifonazole/Triamcinolone Acetonide yet; this page updates once verified.
How do I get a quote for Bifonazole/Triamcinolone Acetonide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-12